These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 520746)

  • 1. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative evaluation of an antiarrhythmic therapy (disopyramide) in patients with frequent premature ventricular contractions (PVC) using a computer-assisted long-term ECG analysis system (author's transl)].
    Weber H; Gloger D; Joskowicz G; Steinbach K
    Z Kardiol; 1981 Jan; 70(1):13-21. PubMed ID: 7210773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of intravenous disopyramide in 126 cases of cardiac rhythm disorders (author's transl)].
    Ducloux G; Faivre G; Perrin A; Raynaud R; Canicave JC; Fauchier JP; Groussin P; Loire R; Saulnier JP
    Ann Cardiol Angeiol (Paris); 1978; 27(4):297-302. PubMed ID: 80150
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacodynamics and pharmacokinetics of disopyramide phosphate].
    Ol'binskaia LI; Tiukavkina NA; Kuz'mina MM; Beloborodov VL; Klimov AV
    Farmakol Toksikol; 1985; 48(4):73-8. PubMed ID: 3930285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)].
    Stauch M; Grewe N
    MMW Munch Med Wochenschr; 1977 Dec; 119(48):1563-6. PubMed ID: 74799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ
    Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous disopyramide on myocardial function in patients with different degrees of cardiac failure.
    Chiariello M; Ferro G; Santinelli V; Tari MG; Spinelli L; Condorelli M
    Jpn Heart J; 1980 Mar; 21(2):197-203. PubMed ID: 7373860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)].
    Smith WS
    Herz; 1978 Dec; 63(36):399-406. PubMed ID: 95482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)].
    Bödeker K; Bischoff KO; Menken U; Hager W
    Z Kardiol; 1980 Nov; 69(11):790-6. PubMed ID: 7467662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
    Breithardt G; Haerten K; Seipel L
    Z Kardiol; 1976 Aug; 65(8):713-23. PubMed ID: 61664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of hemodynamic and coronary effects induced by intravenous injection of disopyramide administered to coronary failure and congestive heart failure patients (author's transl)].
    Pornin M; Roland E; Lardoux H; Sellier P; Morin D; Ourbak P; Maurice P
    Therapie; 1981; 36(2):179-86. PubMed ID: 7292392
    [No Abstract]   [Full Text] [Related]  

  • 15. The hemodynamic effects of Norpace. (Part II).
    Willis PW
    Angiology; 1975 Jan; 26(1 Pt 2):102-10. PubMed ID: 1115396
    [No Abstract]   [Full Text] [Related]  

  • 16. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodynamic effects of propafenone in acute myocardial infarct].
    Finzi A; Ambrosini F; Pagnoni F; Massari FM; Valentini R; Lotto A
    G Ital Cardiol; 1984 May; 14(5):367-72. PubMed ID: 6468818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias.
    Luoma PV; Kujala PA; Juustila HJ; Takkunen JT
    J Clin Pharmacol; 1978; 18(5-6):293-301. PubMed ID: 641217
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiarrhythmic action of disopyramide: a study of plasma levels].
    Page A; Pic A; Besse P
    Arch Mal Coeur Vaiss; 1979 Jul; 72(7):774-80. PubMed ID: 117775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.